Takeda's profit shrank in Q1

Compared to the same quarter last year, the Japanese pharmaceutical firm’s operating profit has dropped 39%.

Photo: Kim Kyung-Hoon/REUTERS / X01368

Takeda Pharmaceuticals has been impacted on its profit and bottom line in the first quarter of fiscal 2022/2023, according to the Japanese firm’s financial report released on Thursday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs